Felix Hannam is a trainee patent attorney within the Life Sciences team and a fluent German speaker having lived there half his life.
He joined Reddie & Grose in September 2022 having completed a MSc in Biomedical Sciences Research and a BSc in Biomedical Sciences from the University of Bristol.
Felix’s masters research project involved investigating the role of p21-activated kinases in prostate cancer initiation as well as their inhibition, with a number of interesting findings including a potential second medical use for a drug previously used in combination therapy targeting ovarian and thyroid cancer.
Prior to starting at Reddie & Grose, he spent 7 months working in industry at the Wellcome Sanger Institute producing physiologically relevant tumour models to further cancer research.
In his spare time, Felix is an avid footballer and keen musician playing the piano, saxophone and cello.
